Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system
- PMID: 3100576
- PMCID: PMC424094
- DOI: 10.1172/JCI112830
Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system
Abstract
Five dogs with mucopolysaccharidosis I, a model of human Hurler/Scheie syndrome, were transplanted with marrow from phenotypically normal littermates at 5 mo of age. At 3 and 9 mo posttransplantation, biopsies of cerebral cortex, liver, and cerebrospinal fluid were obtained. The alpha-L-iduronidase levels in these tissues were 0.8-7.4, 26-45, and 6.3-14.9% of the paired donor tissues, respectively. Although iduronidase was present in relatively low levels in the recipients' brains and cerebrospinal fluid at both biopsy times, reduction in brain glycosaminoglycan (GAG) was comparable to that observed in liver. Ultrastructural studies of cells within the transplanted dogs' brains showed less lysosomal distension and storage product than in affected, nontransplanted, littermate controls. The most marked clearing of stored GAG was in cells surrounding blood vessels, but decreased lysosomal storage in neurons and glial cells was also observed. Urinary GAG excretion also decreased to near normal levels by 5 mo posttransplantation.
Similar articles
-
Bone marrow transplantation for feline mucopolysaccharidosis I.Mol Genet Metab. 2007 Jul;91(3):239-50. doi: 10.1016/j.ymgme.2007.03.001. Epub 2007 May 7. Mol Genet Metab. 2007. PMID: 17482862 Free PMC article.
-
Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).Cell Transplant. 2012;21(7):1577-93. doi: 10.3727/096368912X636894. Cell Transplant. 2012. PMID: 22472595
-
Long-term neurological effects of bone marrow transplantation in a canine lysosomal storage disease.Pediatr Res. 1988 Sep;24(3):347-52. doi: 10.1203/00006450-198809000-00015. Pediatr Res. 1988. PMID: 3145485
-
Enzyme replacement therapy in mucopolysaccharidosis type I.Acta Paediatr Suppl. 2005 Mar;94(447):58-60; discussion 57. doi: 10.1111/j.1651-2227.2005.tb02114.x. Acta Paediatr Suppl. 2005. PMID: 15895714 Review.
-
Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.J Inherit Metab Dis. 2001 Apr;24(2):245-50. doi: 10.1023/a:1010379320378. J Inherit Metab Dis. 2001. PMID: 11405343 Review.
Cited by
-
Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11830-4. doi: 10.1073/pnas.90.24.11830. Proc Natl Acad Sci U S A. 1993. PMID: 8265633 Free PMC article.
-
Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.J Clin Invest. 1997 Apr 1;99(7):1596-605. doi: 10.1172/JCI119322. J Clin Invest. 1997. PMID: 9120003 Free PMC article.
-
Displacement bone marrow transplantation for some inborn errors.J Inherit Metab Dis. 1990;13(4):572-96. doi: 10.1007/BF01799514. J Inherit Metab Dis. 1990. PMID: 2122122 Review.
-
Bone marrow transplants in genetic diseases.Eur J Pediatr. 1992;151 Suppl 1:S44-9. doi: 10.1007/BF02125802. Eur J Pediatr. 1992. PMID: 1345103
-
Bone marrow transplantation for feline mucopolysaccharidosis I.Mol Genet Metab. 2007 Jul;91(3):239-50. doi: 10.1016/j.ymgme.2007.03.001. Epub 2007 May 7. Mol Genet Metab. 2007. PMID: 17482862 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical